Resultats de la cerca - Hacke, Katrin
- Mostrar 1 - 9 resultats de 9
-
1
Genetic modification of mouse bone marrow by lentiviral vector-mediated delivery of HPRT shRNA confers chemoprotection against 6-thioguanine cytotoxicity per Hacke, Katrin, Treger, Janet A., Bogan, Brooke T., Schiestl, Robert H., Kasahara, Noriyuki
Publicat 2013Text -
2
Suppression of HLA Expression by Lentivirus-mediated Gene Transfer of siRNA Cassettes and In Vivo Chemoselection to Enhance Hematopoietic Stem Cell Transplantation per Hacke, Katrin, Falahati, Rustom, Flebbe-Rehwaldt, Linda, Kasahara, Noriyuki, Gaensler, Karin M. L.
Publicat 2009Text -
3
The role of tumour necrosis factor-α and tumour necrosis factor receptor signalling in inflammation-associated systemic genotoxicity per Westbrook, Aya M., Wei, Bo, Hacke, Katrin, Xia, Menghang, Braun, Jonathan, Schiestl, Robert H.
Publicat 2012Text -
4
-
5
Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes? per Cicciarelli, James C., Lemp, Nathan A., Chang, Youngil, Koss, Michael, Hacke, Katrin, Kasahara, Noriyuki, Burns, Kevin M., Min, David I., Naraghi, Robert, Shah, Tariq
Publicat 2017Text -
6
STEM-24. THERAPEUTIC APPROACH OF STEM CELL CARRYING RETROVIRAL REPLICATING VECTORS IN HUMAN GLIOMA MODEL per Inagaki, Akihito, Takahashi, Masamichi, Kamijima, Shuichi, Hiraoka, Kei, Tam, Quincy, Faure-Kumar, Emmanuelle, Treger, Janet, Bogan, Brooke, Hacke, Katrin, Collins, Sara, Jolly, Douglas, Kasahara, Noriyuki
Publicat 2019Text -
7
Combined preconditioning and in vivo chemoselection with 6-thioguanine alone achieves highly efficient reconstitution of normal hematopoiesis with HPRT-deficient bone marrow per Hacke, Katrin, Szakmary, Akos, Cuddihy, Andrew R, Rozengurt, Nora, Lemp, Nathan A, Aubrecht, Jiri, Lawson, Gregory W, Rao, Nagesh P, Crooks, Gay M, Schiestl, Robert H., Kasahara, Noriyuki
Publicat 2011Text -
8
MicroRNA 142-3p Attenuates Spread of Replicating Retroviral Vector in Hematopoietic Lineage-Derived Cells While Maintaining an Antiviral Immune Response per Lin, Amy H., Timberlake, Nina, Logg, Christopher R., Liu, Yanzheng, Kamijima, Shuichi, Diago, Oscar, Wong, Kenneth, Gammon, Dawn K., Ostertag, Derek, Hacke, Katrin, Yang, Emily C., Gruber, Harry, Kasahara, Noriyuki, Jolly, Douglas J.
Publicat 2014Text -
9
Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity per Hiraoka, Kei, Inagaki, Akihito, Kato, Yuki, Huang, Tiffany T., Mitchell, Leah A., Kamijima, Shuichi, Takahashi, Masamichi, Matsumoto, Hiroshi, Hacke, Katrin, Kruse, Carol A., Ostertag, Derek, Robbins, Joan M., Gruber, Harry E., Jolly, Douglas J., Kasahara, Noriyuki
Publicat 2017Text